Jeremy W Tomlinson

Learning pharmacokinetic models for in vivo glucocorticoid activation.

Peter Tiňo, Kerstin Bunte, Wiebke Arlt, 2018, Journal of theoretical biology.

Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis.

Jeremy W Tomlinson, P. Rejto, W. Bartlett, 2007, The Journal of clinical endocrinology and metabolism.

Regulation—the real threat to clinical research

Jeremy W Tomlinson, J. Tomlinson, P. M. Stewart, 2008, BMJ : British Medical Journal.

11β-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess

Zaki K Hassan-Smith, Jeremy W Tomlinson, L. Gathercole, 2014, Proceedings of the National Academy of Sciences.

11 (cid:1) -Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response

Jeremy W Tomlinson, M. Cooper, G. Lavery, 2004 .

11β-Hydroxysteroid dehydrogenase 1: translational and therapeutic aspects.

Jeremy W Tomlinson, M. Cooper, L. Gathercole, 2013, Endocrine reviews.

Gender-Specific Differences in Skeletal Muscle 11β-HSD1 Expression Across Healthy Aging.

Zaki K Hassan-Smith, Jeremy W Tomlinson, G. Lavery, 2015, The Journal of clinical endocrinology and metabolism.